Access, safety and buyer-beware

When Will Retatrutide Be Available?

Medically reviewed by Editorial Medical Review, MD, NAMS-CMP · Updated July 2026

Quick answer

Retatrutide is not available. It is an investigational triple agonist with phase 3 trials ongoing and no FDA approval as of 2026, and no launch date is confirmed. For women interested in it, the practical answer is that approved options exist now, and any product sold online as retatrutide is unapproved and unverified.

Where retatrutide stands in 2026

Retatrutide is an investigational GIP, GLP-1, and glucagon triple agonist. It produced roughly 24% mean weight loss at 48 weeks in a phase 2 trial, which is why it draws attention, but phase 2 is not the end of the process.

As of 2026 it is not FDA-approved and its phase 3 program is ongoing. Phase 3 trials are the large, longer studies regulators require before an approval decision, and they are listed publicly on ClinicalTrials.gov.

Why no honest launch date can be promised

A specific approval or launch date depends on trial completion, data submission, and FDA review, none of which is finalized publicly. Any confident date you see quoted is speculation, not a confirmed timeline.

This matters for planning: choosing to wait for an unapproved drug means going without an approved treatment for an unknown period, which is a decision to make with a clinician rather than around a rumored release.

What to do in the meantime

FDA-approved options are available now: Wegovy (semaglutide) and Zepbound (tirzepatide) for weight, and the diabetes-approved Ozempic and Mounjaro. A clinician can help decide whether starting an approved option now fits your goals better than waiting.

Avoid any product sold online as "retatrutide." Because the drug is only available through registered clinical trials, such products are unapproved and not verified medicines, and the FDA has warned about unapproved weight-loss products generally.

Key points

  • Retatrutide is investigational and not FDA-approved as of 2026.
  • Phase 3 trials are ongoing; no confirmed launch date exists.
  • Waiting for it means going without an approved option in the meantime.
  • Products sold online as retatrutide are unapproved and unverified.

Molecule facts (canonical explainers)

This is a decision guide. For the plain-fact explainer of each molecule (mechanism, FDA status, dosing cautions), see:

Providers we review in this area

Editorial reviews only — not treatment recommendations. Prescribing decisions rest with a licensed clinician. For the full directory, see all GLP-1 for women providers.

  • Form Health — Board-certified obesity medicine physicians prescribing GLP-1s. Often insurance-covered — among the most affordable options when insurance applies.
  • Plushcare GLP-1 — Primary care telehealth that prescribes Wegovy and Zepbound when clinically appropriate. Insurance-friendly.

Cost

Retatrutide has no commercial price because it is not available. Approved-drug costs are covered in our GLP-1 cost guides.

Related questions

Frequently asked questions

Is retatrutide available yet?
No. Retatrutide is investigational, with phase 3 trials ongoing and no FDA approval as of 2026. It is only accessible through registered clinical trials, not by prescription.
When will retatrutide be FDA-approved?
No confirmed date exists. Approval depends on phase 3 completion, data submission, and FDA review, which are not finalized publicly, so any specific date quoted is speculation rather than a confirmed timeline.
Can I buy retatrutide online while I wait?
No. Because retatrutide is only available through registered clinical trials, any product sold online as retatrutide is unapproved and unverified. The FDA has warned about unapproved weight-loss products sold outside the regulated supply chain.

Sources

Every efficacy, safety, and price claim above resolves to an FDA label, published trial, guideline, or manufacturer / GoodRx pricing page. External links open in a new tab.

Keep reading

ClearHormones updates these guides as FDA status and pricing change. Verify current approval status and pricing on the manufacturer or FDA page before acting.